Search research articles
Contact Us
Filters
Showing results (171-180 of 308) with videos related to
Page
of 31
Sort By:
Journal of Medical Screening
|
December 25, 2008
Consensus recommendations for cervical cancer prevention in the Czech Republic: a report of the International Conference on Human Papillomavirus in Human Pathology (Prague, 1-3 May 2008)
Ruth Tachezy, Philip Davies, Marc Arbyn, et al.
Vaccines
|
January 22, 2024
Performance of Human Gene EPB41L3 and HPV 16/18 Viral DNA Methylation to Triage hrHPV-Positive Women
Remila Rezhake, Yan Wang, Xuelian Zhao, et al.
The Lancet. Global Health
|
August 17, 2023
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
Laia Bruni, Ginesa Albero, Jane Rowley, et al.
Vaccine
|
December 17, 2013
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe
Mario Poljak, Katja Seme, Polona J Maver, et al.
Cancer Treatment Reviews
|
March 17, 2004
The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature
Evangelos Paraskevaidis, Marc Arbyn, Alexandros Sotiriadis, et al.
Obstetrics and Gynecology
|
November 28, 2008
Cytologic detection of cervical abnormalities using liquid-based compared with conventional cytology: a randomized controlled trial
Albertus G Siebers, Paul J J M Klinkhamer, Marc Arbyn, et al.
BMJ (Clinical Research Ed.)
|
March 7, 2012
Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
Inge M C M de Kok, Joost van Rosmalen, Joakim Dillner, et al.
Journal of the National Cancer Center
|
July 22, 2024
Risk assessment of self-sampling HPV tests based on PCR, signal amplification to guide the appropriate screening intervals: A prospective study in China
Xuelian Zhao, Shangying Hu, Shuang Zhao, et al.
American Journal of Clinical Pathology
|
September 21, 2021
Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program
Ditte Møller Ejegod, Helle Pedersen, Birgitte Tønnes Pedersen, et al.
Plos One
|
May 25, 2023
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020)
Valerian Mwenda, Joan-Paula Bor, Mary Nyangasi, et al.
Page
of 31
Search research articles
Search
Showing results (171-180 of 308) with videos related to
Sort By:
Page
of 31
Journal of Medical Screening
|
December 25, 2008
Consensus recommendations for cervical cancer prevention in the Czech Republic: a report of the International Conference on Human Papillomavirus in Human Pathology (Prague, 1-3 May 2008)
Ruth Tachezy, Philip Davies, Marc Arbyn, et al.
Vaccines
|
January 22, 2024
Performance of Human Gene EPB41L3 and HPV 16/18 Viral DNA Methylation to Triage hrHPV-Positive Women
Remila Rezhake, Yan Wang, Xuelian Zhao, et al.
The Lancet. Global Health
|
August 17, 2023
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
Laia Bruni, Ginesa Albero, Jane Rowley, et al.
Vaccine
|
December 17, 2013
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe
Mario Poljak, Katja Seme, Polona J Maver, et al.
Cancer Treatment Reviews
|
March 17, 2004
The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature
Evangelos Paraskevaidis, Marc Arbyn, Alexandros Sotiriadis, et al.
Obstetrics and Gynecology
|
November 28, 2008
Cytologic detection of cervical abnormalities using liquid-based compared with conventional cytology: a randomized controlled trial
Albertus G Siebers, Paul J J M Klinkhamer, Marc Arbyn, et al.
BMJ (Clinical Research Ed.)
|
March 7, 2012
Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
Inge M C M de Kok, Joost van Rosmalen, Joakim Dillner, et al.
Journal of the National Cancer Center
|
July 22, 2024
Risk assessment of self-sampling HPV tests based on PCR, signal amplification to guide the appropriate screening intervals: A prospective study in China
Xuelian Zhao, Shangying Hu, Shuang Zhao, et al.
American Journal of Clinical Pathology
|
September 21, 2021
Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program
Ditte Møller Ejegod, Helle Pedersen, Birgitte Tønnes Pedersen, et al.
Plos One
|
May 25, 2023
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020)
Valerian Mwenda, Joan-Paula Bor, Mary Nyangasi, et al.
Page
of 31